Diagnostic Companies


A | C | E | G | M | N | R | S


A


Alvitae Corp.

Current Status: Alvitae is no longer in business.

Company Profile: ALVitae was a biotechnology company developing diagnostics and therapeutics for detection, prevention, and treatment of diseases such as cancer. The company had been developing low-cost, easy-to-operate products for molecular detection of TB with much improved sensitivity and specificity based on its proprietary patented technologies. The products were able to detect as little as one copy of TB in the testing specimen.

Affiliation with Emory: Lilly Yang, MD, PhD, (surgery) Cynthia Cohen, MD, (pathology) and Charles Staley, MD (surgery) are inventors.


Back to top

C


Cardiorisk, LLC

Address: 6777 Nancy Ridge Drive, San Diego, CA 92121

President & CEO: Sergey Sikora

Current Status: In preclinical development

Company Profile: CardioRisk is focusd on diagnostic and prognostic biomarkers. The company’s core business is to develop diagnostic methods using physiological markers to estimate cardiovascular risk. The current technology portfolio of the company includes multiple biomarker blood tests in assessing risk levels in CAD (coronary artery disease) or suspected CAD patients.

Affiliation with Emory: Arshed Quyyumi, M.D. (cardiology) is a scientific co-founder of CardioRisk.


Cardiovascular Specialty Labratories (CPD)

Current Status: Cardiovascular Specialty is no longer in business.

Company Profile: Cardiovascular Specialty Laboratories was established to provide advanced lipid testing to researchers as well as physicians who are interested in the latest in evidence-based tests for the management of cardiovascular disease.

Affiliation with Emory: Joseph Kinkade, PhD (biochemistry), Raymond Shapira, PhD (biochemistry), Peter Jensen, MD (pathology), Ngoc-Anh Le, PhD (endocrinology), Jan Pohl, PhD (medical oncology) and Virgil Brown, PhD (endocrinology) are inventors.

Back to top

E


Emtherapro, INC.

Address: 1374 Pasadena Avenue NE, Atlanta, GA 30306
Emtherapro website

CEO: Kiran Pandey

Current Status: Products on the market

Company Profile: Emtherapro is focused on biomarkers and therapies for neurodegenerative diseases by leveraging advances.

Affiliation to Emory: Nicholas Seyfried, PhD (biochemistry), Duc Duong, PhD (core labs), Allan Levey MD, PhD (neurology), Maotian Zhou, PhD (neurology), James Lah, Erik Johnson, MD, PhD (neurology) and Lenora Higginbotham, MD (neurology) are inventors.

Back to top

G


Genomalytics LTD.

Current Status: Genomalytics is no longer in business.

Company Profile: Genomalytics was formed to provide genomic information and analysis at scale with precision. Genomalytics Sequencing Tools and Analytics (GLSTA) permits the rapid, full length sequencing of millions of individual messenger RNA and other RNA molecules that dictate the biological properties of a cell or tissue. GLSTA employs a technique termed “virtual cloning” that eliminates the need to physically clone complementary DNA (cDNA) and dramatically enhances the output and accuracy of results.

Affiliation with Emory: William Agnew, PhD (physiology) is a scientific co-founder.


Back to top

M


Microbial Medical, Inc.

Address: 3070 Windward Plaza Suite 279F Alpharetta, GA 30005

President & CEO: Michael Wach

Current Status: In preclinical development

Company Profile: Microbial Medical develops imaging agents for the non-invasive detection of bacteria in humans focused on detection in early stages of infections with accuracy or distinguish between infection and inflammation. The inventors developed a technology that employs sugars termed maltodextrins that specifically target the maltodextrin transporter which is uniquely present in all bacteria. The company’s product pipeline includes novel imaging agents and drugs for diagnosing (using common medical scanners) and treating bacterial and fungal infections.

Affiliation with Emory: W. Robert Taylor, MD, PhD (cardiology) and Mark Goodman, PhD (radiology and imaging sciences) are scientific co-founders.

Back to top

N


Nanomarq Diagnostics, Inc.

Current Status: NanoMarq is no longer in business.

Company Profile: The company was a spinout company of Cell Marque focused on an immunohistochemical diagnostic technology.

Affiliation with Emory: Shuming Nie, PhD (medical oncology) is an inventor.

Back to top

R


Raybiotech, Inc.

Current Status: RayBiotech no longer has a license to Emory technology.

Company Profile: RayBiotech provides proteomics tools for the advancement of basic and clinical research, the development of better patient diagnostics and the facilitation of drug discovery. The company has pioneered the development of antibody and protein array technology to efficiently analyze the expression and function of hundreds of proteins involved in inflammation, angiogenesis, cell growth, and signal transduction from a single biological sample.

Affiliation to Emory: Ruo-Pan (Ray) Huang, MD, PhD (gynecology & obstetrics) was a founder.


ResonanceDX, Inc.

Address: 45 E. Trinity Pl. #1529, Decatur, GA 30030
ResonanceDX website

President and CEO: John E. Ashley

Current Status: In preclinical development

Company Profile: ResonanceDx is developing a unique resonance frequency based diagnostic platform for rapid identification of a wide range of bacterial, viral and fungal infections. Quick (15 mins) diagnostic information aids physicians in prescribing appropriate medications and could reduce the over-prescription of antibiotics. While the initial focus is infectious disease, the company’s platform technology can be used to detect biomarkers for any disease indication.

Affiliation to Emory: Carlos Moreno, PhD (pathology and laboratory medicine), Paul Doetsch, PhD (biochemistry), Georgia Chen, PhD (hematology & medical oncology), and Dong Shin, MD (hematology & medical oncology) are scientific co-founders.

Back to top

S


Sanguina, LLC

Address: 147 Technology Parkway, Ste 100, Peachtree Corners, GA 30092
Sanguina website

CEO: Erika Tyburski

Current Status: Products on the market

Company Profile: Sanguina has developed AnemoCheck, a multi-product, anemia management platform consisting of an app and anin vitro diagnostic device for clinical and over the counter hemoglobin determination. The AnemoCheck app, AnemoCheck Mobile is a non-invasive app that estimates hemoglobin with an image capture of fingernail beds. AnemoCheck is a color-based screening test for anemia. Each test requires less than half a drop of blood from a finger stick.

Affiliation to Emory: Wilbur Lam, MD, PhD (pediatrics) is the scientific founder and inventor.


Syntermed, Inc.

Address: 130 West Wieuca Road, Suite 108, Atlanta, GA 30342
Syntermed website

Chairman and CEO: Michael Lee

Current Status: Products on the market

Company Profile: Syntermed's lead product is a software package called Emory Cardiac ToolboxTM (ECTbTM).  The Emory Cardiac Toolbox provides physicians with the ability to process, display, interpret and analyze cardiac positron emission tomography (PET) and single-photon computed tomography (SPECT) images. By displaying three-dimensional images of the patient's heart, the Toolbox allows physicians to see whether or not blood is flowing to all areas of the myocardium and can determine the heart's efficiency. The company is developing new automated analysis tools to allow efficient identification of cardiac risks.

Affiliation to Emory: Ernest Garcia, PhD (radiology) and his colleagues are inventors.


Back to top